DENTSPLY SIRONA (NASDAQ:XRAY) Price Target Cut to $30.00

DENTSPLY SIRONA (NASDAQ:XRAY) had its price objective reduced by stock analysts at The Goldman Sachs Group from $34.00 to $30.00 in a report released on Monday, Benzinga reports. The brokerage currently has a “neutral” rating on the medical instruments supplier’s stock. The Goldman Sachs Group’s price target suggests a potential upside of 6.19% from the stock’s previous close.

A number of other research firms have also recently issued reports on XRAY. Robert W. Baird lowered their price objective on DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating on the stock in a research report on Friday, May 3rd. SVB Leerink assumed coverage on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. They issued an “outperform” rating and a $42.00 price objective for the company. Evercore ISI lowered their target price on shares of DENTSPLY SIRONA from $40.00 to $35.00 and set an “outperform” rating on the stock in a research note on Friday, May 3rd. Barrington Research cut their price target on shares of DENTSPLY SIRONA from $41.00 to $38.00 and set an “outperform” rating for the company in a research note on Friday, May 3rd. Finally, StockNews.com downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Friday, May 3rd. Five equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, DENTSPLY SIRONA presently has an average rating of “Moderate Buy” and a consensus price target of $35.22.

DENTSPLY SIRONA Stock Performance

NASDAQ:XRAY opened at $28.25 on Monday. The company’s 50 day moving average is $31.91 and its 200-day moving average is $32.66. The company has a quick ratio of 0.97, a current ratio of 1.43 and a debt-to-equity ratio of 0.54. DENTSPLY SIRONA has a 12 month low of $26.27 and a 12 month high of $41.65. The firm has a market cap of $5.87 billion, a price-to-earnings ratio of -64.20, a P/E/G ratio of 1.24 and a beta of 1.00.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.42. The firm had revenue of $953.00 million during the quarter, compared to analyst estimates of $969.45 million. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The business’s revenue was down 2.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.39 EPS. Equities analysts anticipate that DENTSPLY SIRONA will post 2.04 EPS for the current year.

Institutional Trading of DENTSPLY SIRONA

Large investors have recently bought and sold shares of the business. VisionPoint Advisory Group LLC lifted its holdings in shares of DENTSPLY SIRONA by 104.2% in the third quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock valued at $26,000 after purchasing an additional 395 shares in the last quarter. Principal Securities Inc. acquired a new position in DENTSPLY SIRONA during the 4th quarter worth approximately $26,000. Headlands Technologies LLC bought a new position in shares of DENTSPLY SIRONA during the 4th quarter worth approximately $30,000. Parkside Financial Bank & Trust raised its holdings in shares of DENTSPLY SIRONA by 33.3% in the fourth quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock valued at $42,000 after purchasing an additional 292 shares during the last quarter. Finally, Anchor Investment Management LLC bought a new stake in shares of DENTSPLY SIRONA in the fourth quarter worth $47,000. 95.70% of the stock is owned by institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.